Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

169 Press Releases
DateTitleCompany
20 Jun 14 Forest Laboratories, Inc. to Present Cariprazine Data at the International College of Neuropsychopharmacology World Congress Forest Laboratories Inc.,
Published by
Business Wire
18 Jun 14 Forest Obtains Six Months U.S. Pediatric Exclusivity for NAMENDA® and NAMENDA XR® Forest Laboratories Inc.,
Published by
Business Wire
16 May 14 Forest Laboratories, Inc. to Present Nebivolol/Valsartan Fixed-Dose Combination Data at the American Society of Hypertension Annual Scientific Meeting Forest Laboratories Inc.,
Published by
Business Wire
09 Apr 14 Forest Laboratories and Almirall Provide Update on the Fixed Dose Combination of Aclidinium and Formoterol in the U.S. Forest Laboratories Inc.,
Published by
Business Wire
01 Apr 14 Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2014 Fourth Quarter Earnings Forest Laboratories Inc.,
Published by
Business Wire
21 Mar 14 Forest Laboratories, Inc. and Gedeon Richter Plc. Announce Positive Phase IIb Topline Results for Cariprazine as Adjunctive Therapy in the Treatment of Major Depressive Disorder Forest Laboratories Inc.,
Published by
Business Wire
04 Mar 14 Forest Laboratories and Adamas Pharmaceuticals Announce Forest’s Submission of New Drug Application for Memantine Extended Release and Donepezil Fixed-Dose Combination for Alzheimer’s Disease Forest Laboratories Inc.,
Published by
Business Wire
27 Feb 14 Forest Laboratories Submits a New Drug Application for Nebivolol and Valsartan Combination in Hypertension Forest Laboratories Inc.,
Published by
Business Wire
03 Feb 14 Forest Laboratories, Inc. Completes $2.9B Acquisition of Aptalis Forest Laboratories Inc.,
Published by
Business Wire
31 Jan 14 Forest Laboratories, Inc. Files Lawsuit Against Several Companies for Infringement of NAMENDA XR® Patents Forest Laboratories Inc.,
Published by
Business Wire
28 Jan 14 Forest Laboratories, Inc. Prices Offering of $1.8 Billion in Senior Notes Forest Laboratories Inc.,
Published by
Business Wire
27 Jan 14 Forest Laboratories, Inc. Announces Private Placement of Senior Notes Forest Laboratories Inc.,
Published by
Business Wire
13 Jan 14 Forest Laboratories Pursues Additional Market Exclusivity to Extend Namenda Patent Forest Laboratories Inc.,
Published by
Business Wire
10 Jan 14 Forest Laboratories Names Karen L. Ling Senior Vice President, Chief Human Resources Officer Forest Laboratories Inc.,
Published by
Business Wire
08 Jan 14 Forest Laboratories to Acquire Aptalis for $2.9 Billion in Cash Forest Laboratories Inc.,
Published by
Business Wire
02 Jan 14 Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2014 Third Quarter Earnings Forest Laboratories Inc.,
Published by
Business Wire
09 Dec 13 Forest Laboratories Announces Appointments to its Executive Team Forest Laboratories Inc.,
Published by
Business Wire
05 Dec 13 Forest Laboratories, Inc. Upsizes and Prices Offering of $1.2 Billion of Senior Notes Due 2021 Forest Laboratories Inc.,
Published by
Business Wire
13 Sep 13 Ceftazidime/avibactam Combination Receives Qualified Infectious Disease Product (QIDP) Designation from FDA Forest Laboratories Inc.,
Published by
Business Wire
01 Oct 13 Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2014 Second Quarter Earnings Forest Laboratories Inc.,
Published by
Business Wire
07 Nov 13 Forest Laboratories, Inc. Announces Settlement of BYSTOLIC® Patent Litigation Forest Laboratories Inc.,
Published by
Business Wire
02 Oct 13 Forest Laboratories, Inc. Files Additional Lawsuit against First Time US Generics LLC for Infringement of SAVELLA® Patents Forest Laboratories Inc.,
Published by
Business Wire
14 Aug 13 Forest Laboratories and Almirall Decide to Delay NDA Filing for Aclidinium/formoterol Combination Forest Laboratories Inc. and Almirall S.A.,
Published by
Business Wire
24 Sep 13 Forest Laboratories, Inc. Files Lawsuits against Several Companies for Infringement of Savella® Patents Forest Laboratories Inc.,
Published by
Business Wire
02 Dec 13 Forest Laboratories, Inc. Announces Private Placement of Senior Notes and Amendment to Existing $750 Million Revolver Forest Laboratories Inc.,
Published by
Business Wire
02 Dec 13 Forest Announces Major New Plans to Streamline Operations, Leverage Balance Sheet and Repurchase Common Stock Forest Laboratories Inc.,
Published by
Business Wire
21 Nov 13 Forest Laboratories and Gedeon Richter Receive Complete Response Letter for Cariprazine Forest Laboratories Inc.,
Published by
Business Wire
10 Sep 13 Forest Laboratories Names Brent Saunders CEO and President Forest Laboratories Inc.,
Published by
Business Wire
01 Jul 13 Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2014 First Quarter Earnings Forest Laboratories Inc.,
Published by
Business Wire
27 Jun 13 Forest Laboratories Announces Positive Phase III Study Results for Nebivolol and Valsartan Combination in Hypertension Forest Laboratories Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.